谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Safety and Clinical Activity of Subcutaneously (SC) Administered Anti-Pd-1 Antibody PF-06801591 in Phase I Dose-Expansion Cohorts of Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) and Urothelial Carcinoma (UC)

B. C. Cho,K. Penkov,I. Bondarenko, M. Korozan, A. Kurochkin,J. Pikiel,Y. Kulyaba,H. K. Ahn, S. Odintsova,J. Davda,A. Forgie, X. Wang,R. Li,I. A. Jacobs, F. Kazazi, J. Chou,M. L. Johnson

Annals of oncology（2019）

引用 1|浏览41
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要